Indeed, Crkl, which seems to drive the activation of p110β in PTEN-deficient cancer cells [37], was significantly increased in PC tumors from Pten/Rb-null vs. Akap12/Rb-null mice. This evidence concerns the gene RB1 and pachyonychia congenita.